Search - tctmd.com

Displaying 301 - 320 of 598

Sort: Relevancy | Date

News Conference News EuroPCR 2020

Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR

L.A. McKeown

July 01, 2020

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Daily News

Infective Endocarditis After TAVR Rare but Has Serious Consequences: SwissTAVI

L.A. McKeown

June 16, 2020

News Daily News

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Yael L. Maxwell

June 10, 2020

News Daily News

Cardiogenic Shock Spells Poor Outcomes Despite Successful TAVR

Todd Neale

June 02, 2020

Presentation

In-hospital Outcomes and Readmissions forValve-in-Valve TAVR vs Surgical Redo

June 01, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

News Conference News ACC 2020

UK TAVI: Real-world TAVR and SAVR Have Similar 1-Year Mortality

L.A. McKeown

March 29, 2020

News Daily News

Meta-analysis Reassures on Benefits of TAVR in Cancer Patients

L.A. McKeown

March 16, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

News Daily News

Meta-analysis Questions PCI vs CABG in Women With Multivessel Disease

Shelley Wood

February 27, 2020

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

News Daily News

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

Michael O'Riordan

February 13, 2020

News Conference News STS 2020

Dedicated Structural Heart Training Pathway in the Works for Surgeons

Yael L. Maxwell

February 04, 2020

News Conference News STS 2020

For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns

Yael L. Maxwell

January 30, 2020

News Daily News

Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows

Todd Neale

January 29, 2020

Advertisement

Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Infective Endocarditis After TAVR Rare but Has Serious Consequences: SwissTAVI

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Cardiogenic Shock Spells Poor Outcomes Despite Successful TAVR

In-hospital Outcomes and Readmissions forValve-in-Valve TAVR vs Surgical Redo

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

UK TAVI: Real-world TAVR and SAVR Have Similar 1-Year Mortality

Meta-analysis Reassures on Benefits of TAVR in Cancer Patients

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Meta-analysis Questions PCI vs CABG in Women With Multivessel Disease

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

Dedicated Structural Heart Training Pathway in the Works for Surgeons

For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns

Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content